Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study

Abstract

Controversy exists concerning the prevalence of headache in systemic lupus erythematosus (SLE) and its importance as a neuropsychiatric manifestation, especially when it occurs independently of disease activity and with the typical characteristics of primary chronic headache. Most reports to date have either studied both types of headache, whether or not related to systemic lupus erythematosus, or have not used adequate controls.

This study determines the prevalence and types of chronic primary headache in patients with systemic lupus erythematosus in a case-control study which we performed in a tertiary care hospital.

We studied 71 consecutive patients with systemic lupus erythematosus and 71 healthy unrelated subjects matched for age and sex from the same geographical area.

Clinical evaluation using a specific standard protocol for the presence and characteristics of headache according to the operative classification criteria of the International Headache Society.

The overall prevalence of headache, tension-type headache, and migraine was similar among patients and controls [33 (46.5%), 17 (23.9%) and 16 (22.5%) vs 31 (43.7%), 17 (23.9%) and 13 (18.3%), respectively]. The mean age of onset of headache was higher in the patients (28.7–14.3 vs 18.5–5.6 y; P = 0.001) and the subjective response to analgesics was lower than in the controls [19 (63%) vs 28 (93.3%); P = 0.004]. There were no differences in the presence of precipitating factors or family history of headache. There were no relevant clinical or immunological differences among the patients regarding the presence or absence of tension-type headache or migraine.

Patients with systemic lupus erythematosus do not differ from healthy controls for the presence and type of chronic or recurrent headache.

Keywords

chronic or recurrent headache systemic lupus erythematosus (SLE)prevalence

Get full access to this article

View all access options for this article.

References

Kovacs JAJ , Urowitz MB , Gladman DD . Dilemmas in neuropsychiatric lupus . Rheum Dis Clin North Am 1993; 19: 795–814 .

Wallace DJ , Metzger AL . Systemic lupus erythematosus and the nervous system. In: Wallace DJ , Hahn H (eds). Dubois' Lupus Erythematosus, 5th ed. Williams & Wilkins: Baltimore , 1997; pp 723–754.

Brandt KD , Lessell S . Migrainous phenomena in systemic lupus erythematosus . Arthritis Rheum 1978; 21: 7–16 .

Abel T , Gladman DD , Urowitz MB . Neuropsychiatric lupus . J Rheumatol 1980; 7: 325–333 .

Atkinson RA , Appenzeller O . Headache in small vessel disease of brain: a study of patients with systemic lupus erythematosus . Headache 1975; 15: 198–201 .

Pryse-Phillips W et al. A canadian population survey on the clinical epidemiologic and societal impact of migraine and tension-type headache . Can J Neurol Sci 1992; 19: 333–339 .

Hochberg MC . Up dating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1997; 40: 1725-1725 .

Headache classification committee of the International Headache Society . Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain . Cephalalgia 1988; 8 (Suppl 7): 1–96 .

Bracci-Laudiero L et al. Increased levels of NGF in sera of systemic lupus erythematosus patients . Neuroreport 1993; 5: 563–565 .

10.

Brandt JT , Barna LK , Triplett DA . Laboratory identification of lupus anticoagulants: Results of the Second International Workshop for identification of lupus anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH . Thromb Haemost 1995; 74: 1597–1603 .

11.

Migliaresi S et al. Neurological manifestations of systemic lupus erythematosus. Study of 53 cases . Ann Ital Med Int 1989; 4: 10–15 .

12.

Anzola GP , Dalla Volta G , Balestrieri G . Headache in patients with systemic lupus erythematosus: clinical and telethermographic findings . Arch Neurol 1988; 45: 1061–1062 .

13.

Vázquez-Cruz J et al. A prospective study of chronic or recurrent headache in systemic lupus erythematosus . Headache 1990; 30: 232–235 .

14.

Isenberg DA et al. A study of migraine in systemic lupus erythematosus . Ann Rheum Dis 1982; 41: 30–32 .

15.

Markus HS , Hopkinson N . Migraine and headache in systemic lupus erythematosus and their relationship with antibodies against phospholipids . J Neurol 1992; 239: 39–42 .

16.

Tan CT , Hentzen A , Alders EEA . Systemic lupus erythematosus and headache [Abstract] . Neurology 1996; 46: A153-A153 .

17.

Merikangas KR , Whitaker AE , Angst J . Validation of diagnostic criteria for migraine in the Zurich longitudinal cohort study . Cephalalgia 1993; 13: 47–53 .

18.

Rasmussen BK , Jensen R , Schroll M , Olesen J . Epidemiology of headache in general population<Eth>a prevalence study . J Clin Epidemiol 1991; 44: 1147–1157 .

19.

Russell MB , Rasmussen BK , Fenger K , Olesen J . Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population . Cephalalgia 1996; 16: 239–245 .

20.

Bartelink ML et al. Migraine in family practice: prevalence and influence of sex hormonal status . Fam Med 1993; 25: 331–336 .

21.

Mathew NT , Stubits E , Nigam M . Transformation of episodic migraine into daily headache analysis of factors . Headache 1982; 22: 66–68 .

22.

Miller D et al. Is variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med 1981; 304: 763–766 .

23.

Zahavi I et al. Prevalence of Raynaud's phenomenon in patients with migraine . Arch Intern Med 1984; 144: 742–744 .

24.

Riera G et al. Prevalence of Raynaud's phenomenon in a healthy Spanish population . J Rheumatol 1993; 20: 66–69 .

25.

O'Keeffe ST , Tsapatsaris NP , Beetham WP Jr. Increased prevalence of migraine and chest pain in patients with primary Raynaud disease . Ann Intern Med 1992; 116: 985–989 .

26.

Cervera R et al. Systemic lupus erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1000 patients . Medicine (Baltimore) 1993; 72: 113–124 .

27.

Montalbán J et al. Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus . Neurology 1992; 42: 681–682 .

28.

Alarcón-Segovia D et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients . Medicine (Baltimore) 1989; 68: 353–365 .